Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Oral Anticoagulant”

174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 174 results

Large-scale testing (Phase 3)UnknownNCT04891861
What this trial is testing

Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage

Who this might be right for
Anticoagulants; Increased
University of Texas at Austin 100
Not applicableEnded earlyNCT05093504
What this trial is testing

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

Who this might be right for
Hemorrhage, SurgicalHemorrhage PostoperativeBlood Loss, Surgical+1 more
CytoSorbents, Inc 9
Post-approval studies (Phase 4)Study completedNCT07354230
What this trial is testing

Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACs

Who this might be right for
Atrial Fibrillation (AF)
Pirogov Russian National Research Medical University 210
Not applicableLooking for participantsNCT06232551
What this trial is testing

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Who this might be right for
Venous Thromboembolic DiseasePulmonary Embolism and ThrombosisDeep Vein Thrombosis+1 more
Scott C. Woller, MD 152,000
Not applicableStudy completedNCT03778502
What this trial is testing

DOAC in Unusual Site Venous Thrombosis

Who this might be right for
Splanchnic Vein ThrombosisCerebral Vein ThrombosisOvarian Vein Thrombosis+2 more
University of Malta 358
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Post-approval studies (Phase 4)Looking for participantsNCT04436978
What this trial is testing

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionAtrial Fibrillation+8 more
St. Antonius Hospital 2,000
Very early researchNot Yet RecruitingNCT07011095
What this trial is testing

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

Who this might be right for
Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)
Population Health Research Institute 100
Not applicableLooking for participantsNCT06696079
What this trial is testing

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

Who this might be right for
Chronic Subdural HematomaAtrial Fibrillation (AF)
Rahul Raj 332
Not applicableLooking for participantsNCT07384013
What this trial is testing

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Who this might be right for
Oncologic DiseasesCoagulation DefectPain Management
Rambam Health Care Campus 30
Testing effectiveness (Phase 2)WithdrawnNCT04002011
What this trial is testing

DOAC Versus VKA After Cardiac Surgery

Who this might be right for
Anticoagulant-induced Bleeding
Laval University
Post-approval studies (Phase 4)UnknownNCT05292846
What this trial is testing

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures

Who this might be right for
Coronary Artery DiseaseBleedingDirect Acting Anticoagulant Adverse Reaction
Hospital Universitario La Fe 200
Large-scale testing (Phase 3)UnknownNCT04141254
What this trial is testing

Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 150
Not applicableStudy completedNCT03344146
What this trial is testing

Electronic Monitoring and Improvement of Adherence to DOACs in Polymedicated Stroke Patients

Who this might be right for
Adherence, PatientStroke, Ischemic
University Hospital, Basel, Switzerland 130
Large-scale testing (Phase 3)Study completedNCT02066454
What this trial is testing

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Who this might be right for
MyelomaVenous Thromboembolism
University Hospital, Grenoble 108
Not applicableStudy completedNCT06239402
What this trial is testing

Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

Who this might be right for
Atrial Fibrillation
Istituti Clinici Scientifici Maugeri SpA 394
Not applicableStudy completedNCT03596502
What this trial is testing

Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 402,764
Not applicableLooking for participantsNCT05378035
What this trial is testing

DOAC in Chinese Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeStroke, Acute+4 more
Chinese University of Hong Kong 427
Not applicableLooking for participantsNCT06194617
What this trial is testing

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

Who this might be right for
Pulmonary EmbolismVenous ThromboembolismAnticoagulant-induced Bleeding
Peking Union Medical College Hospital 300
Not applicableStudy completedNCT03187197
What this trial is testing

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,315
Load More Results